SONOMA PHARMACEUTICALS, INC. Debt Instrument, Interest Rate, Stated Percentage
SONOMA PHARMACEUTICALS, INC. (SNOA) had Debt Instrument, Interest Rate, Stated Percentage of 15.00% as of 2026-03-31, per its 10-K filed 2026-06-16.
Financial Statements › Notes › Debt Instruments
us-gaap:DebtInstrumentInterestRateStatedPercentage · last filed 2026-06-16
- 2026-03-31: Debt Instrument, Interest Rate, Stated Percentage 15.00%.
| Period end | Debt Instrument, Interest Rate, Stated Percentage |
|---|---|
| 2026-03-31 | 15.00% 10-K · filed 2026-06-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |